Records 1 - 2
| Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment.
Thoracic cancer 2021 Jul .
Cheng Wanwan, Xu Bin, Zhang Haitao, Fang Shenc
| Comparison of therapeutic effects of EGFR-tyrosine kinase inhibitors on 19Del and L858R mutations in advanced lung adenocarcinoma and effect on cellular immune function.
Thoracic cancer 2017 Dec .
Zhou Juan, Ben Suq